Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 52


Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder.

Kessler RC, van Loo HM, Wardenaar KJ, Bossarte RM, Brenner LA, Ebert DD, de Jonge P, Nierenberg AA, Rosellini AJ, Sampson NA, Schoevers RA, Wilcox MA, Zaslavsky AM.

Epidemiol Psychiatr Sci. 2016 Jan 26:1-15. [Epub ahead of print]


Testing a machine-learning algorithm to predict the persistence and severity of major depressive disorder from baseline self-reports.

Kessler RC, van Loo HM, Wardenaar KJ, Bossarte RM, Brenner LA, Cai T, Ebert DD, Hwang I, Li J, de Jonge P, Nierenberg AA, Petukhova MV, Rosellini AJ, Sampson NA, Schoevers RA, Wilcox MA, Zaslavsky AM.

Mol Psychiatry. 2016 Jan 5. doi: 10.1038/mp.2015.198. [Epub ahead of print]


Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.

Wang Y, Berlin JA, Pinheiro J, Wilcox MA.

Clin Trials. 2015 Jun;12(3):265-75. doi: 10.1177/1740774515572352. Epub 2015 Mar 1.


Anxious and non-anxious major depressive disorder in the World Health Organization World Mental Health Surveys.

Kessler RC, Sampson NA, Berglund P, Gruber MJ, Al-Hamzawi A, Andrade L, Bunting B, Demyttenaere K, Florescu S, de Girolamo G, Gureje O, He Y, Hu C, Huang Y, Karam E, Kovess-Masfety V, Lee S, Levinson D, Medina Mora ME, Moskalewicz J, Nakamura Y, Navarro-Mateu F, Browne MA, Piazza M, Posada-Villa J, Slade T, Ten Have M, Torres Y, Vilagut G, Xavier M, Zarkov Z, Shahly V, Wilcox MA.

Epidemiol Psychiatr Sci. 2015 Jun;24(3):210-26. doi: 10.1017/S2045796015000189. Epub 2015 Feb 27.


The effects of co-morbidity in defining major depression subtypes associated with long-term course and severity.

Wardenaar KJ, van Loo HM, Cai T, Fava M, Gruber MJ, Li J, de Jonge P, Nierenberg AA, Petukhova MV, Rose S, Sampson NA, Schoevers RA, Wilcox MA, Alonso J, Bromet EJ, Bunting B, Florescu SE, Fukao A, Gureje O, Hu C, Huang YQ, Karam AN, Levinson D, Medina Mora ME, Posada-Villa J, Scott KM, Taib NI, Viana MC, Xavier M, Zarkov Z, Kessler RC.

Psychol Med. 2014 Nov;44(15):3289-302. doi: 10.1017/S0033291714000993. Epub 2014 Jul 17.


Major depressive disorder subtypes to predict long-term course.

van Loo HM, Cai T, Gruber MJ, Li J, de Jonge P, Petukhova M, Rose S, Sampson NA, Schoevers RA, Wardenaar KJ, Wilcox MA, Al-Hamzawi AO, Andrade LH, Bromet EJ, Bunting B, Fayyad J, Florescu SE, Gureje O, Hu C, Huang Y, Levinson D, Medina-Mora ME, Nakane Y, Posada-Villa J, Scott KM, Xavier M, Zarkov Z, Kessler RC.

Depress Anxiety. 2014 Sep;31(9):765-77. doi: 10.1002/da.22233. Epub 2014 Jan 14.


Highly cited publications in pediatric neurosurgery.

Wilcox MA, Khan NR, McAbee JH, Boop FA, Klimo P Jr.

Childs Nerv Syst. 2013 Dec;29(12):2201-13. doi: 10.1007/s00381-013-2228-z. Epub 2013 Jul 31.


Rare variant collapsing in conjunction with mean log p-value and gradient boosting approaches applied to Genetic Analysis Workshop 17 data.

Cherkas Y, Raghavan N, Francke S, Defalco F, Wilcox MA.

BMC Proc. 2011 Nov 29;5 Suppl 9:S94. doi: 10.1186/1753-6561-5-S9-S94. Epub 2011 Nov 29.


Statistical epistasis and progressive brain change in schizophrenia: an approach for examining the relationships between multiple genes.

Andreasen NC, Wilcox MA, Ho BC, Epping E, Ziebell S, Zeien E, Weiss B, Wassink T.

Mol Psychiatry. 2012 Nov;17(11):1093-102. doi: 10.1038/mp.2011.108. Epub 2011 Aug 30.


A defective Il15 allele underlies the deficiency in natural killer cell activity in nonobese diabetic mice.

Suwanai H, Wilcox MA, Mathis D, Benoist C.

Proc Natl Acad Sci U S A. 2010 May 18;107(20):9305-10. doi: 10.1073/pnas.1004492107. Epub 2010 May 3.


Development of real-time PCR assays for detection of the Streptococcus milleri group from cystic fibrosis clinical specimens by targeting the cpn60 and 16S rRNA genes.

Olson AB, Sibley CD, Schmidt L, Wilcox MA, Surette MG, Corbett CR.

J Clin Microbiol. 2010 Apr;48(4):1150-60. doi: 10.1128/JCM.02082-09. Epub 2010 Feb 17.


Genetic Analysis Workshop 16: Strategies for genome-wide association study analyses.

Cupples LA, Beyene J, Bickeböller H, Daw EW, Fallin MD, Gauderman WJ, Ghosh S, Goode EL, Hauser ER, Hinrichs A, Kent JW Jr, Martin LJ, Martinez M, Neuman RJ, Province M, Szymczak S, Wilcox MA, Ziegler A, Maccluer JW, Almasy L.

BMC Proc. 2009 Dec 15;3 Suppl 7:S1. No abstract available.


Phenotype definition and development--contributions from Group 7.

Wilcox MA, Paterson AD.

Genet Epidemiol. 2009;33 Suppl 1:S40-4. doi: 10.1002/gepi.20471.


Genetic Analysis Workshop 15: gene expression analysis and approaches to detecting multiple functional loci.

Cordell HJ, de Andrade M, Babron MC, Bartlett CW, Beyene J, Bickeböller H, Culverhouse R, Cupples LA, Daw EW, Dupuis J, Falk CT, Ghosh S, Goddard KA, Goode EL, Hauser ER, Martin LJ, Martinez M, North KE, Saccone NL, Schmidt S, Tapper W, Thomas D, Tritchler D, Vieland VJ, Wijsman EM, Wilcox MA, Witte JS, Yang Q, Ziegler A, Almasy L, Maccluer JW.

BMC Proc. 2007;1 Suppl 1:S1. Epub 2007 Dec 18. No abstract available.


Genetic association with rheumatoid arthritis-Genetic Analysis Workshop 15: summary of contributions from Group 2.

Wilcox MA, Li Z, Tapper W, Browning S, Curtin K, Ding J, Ding Y, Gagnon F, He Q, Kuo TY, Li M, Matthew G, Mei L, Rao S, Shaw J, Wei Z, Yu Z, Zhang W, Zheng T, Zhu G.

Genet Epidemiol. 2007;31 Suppl 1:S12-21.


Identification of abacavir hypersensitivity reaction in health care claims data.

Nordstrom BL, Norman HS, Dube TJ, Wilcox MA, Walker AM.

Pharmacoepidemiol Drug Saf. 2007 Mar;16(3):289-96.


Serum heat shock protein 70 level as a biomarker of exceptional longevity.

Terry DF, Wyszynski DF, Nolan VG, Atzmon G, Schoenhofen EA, Pennington JY, Andersen SL, Wilcox MA, Farrer LA, Barzilai N, Baldwin CT, Asea A.

Mech Ageing Dev. 2006 Nov;127(11):862-8. Epub 2006 Oct 6.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk